T4K3.news
Gummy recall due to unlisted melatonin
UK health authorities urge stopping use and disposing of Nutrition Ignition gummies after tests found melatonin not listed on packaging.
UK health officials alert parents after testing finds unlisted melatonin in a raspberry flavored kids gummy, triggering a broad recall.
Gummy recall raises safety concerns about unlisted melatonin in kids products
UK medicines regulator MHRA issued an urgent recall of Nutrition Ignition Kids Magnesium Glycinate Gummies after lab tests found melatonin in two batches. The agency says the ingredient was not listed on the packaging. Lab results showed 1.5 to 1.7 mg of melatonin per gummy. The recall covers all batches and parents are urged to stop using the product and dispose of any remaining gummies.
The MHRA notes melatonin is a prescription or closely regulated sleep aid in the UK and warns of potential side effects in children such as headaches, dizziness and stomach pain. The agency also mentions reports of melatonin overdoses and at least two infant deaths linked to its use. Melatonin gummies are sold in other countries without prescription, but the UK faces tighter rules and the Yellow Card safety reporting system tracks adverse effects to inform warnings or withdrawals.
Key Takeaways
"We advise any parent or caregiver to stop use of this product and safely dispose of it."
MHRA safety guidance cited in the alert
"Side effects such as headache, hyperactivity, a feeling of dizziness and abdominal pain have been reported in children when melatonin is prescribed."
risk information provided by MHRA
"Testing of two batches found melatonin levels of between 1.5 and 1.7 mg in individual gummies."
lab findings in MHRA alert
"Melatonin gummies are available in China, the US and in some European countries without prescription despite doubts about their long term safety."
global market framing
This recall highlights how quickly a sleep aid marketed to children can slip into consumer shelves when labeling lags behind demand. When a product is treated as a wellness supplement, dose details may not be clear to families choosing a bedtime aid. The situation is a reminder that consumer products cross borders fast, while regulatory safeguards often lag. Regulators face pressure to tighten labeling and testing rules for supplements aimed at children to restore trust and reduce risk.
The episode also exposes a gap between marketing and medicine. Clear, consistent disclosure of ingredients and doses is essential, especially when the ingredient carries real medical implications. The MHRA alert underscores the need for ongoing oversight of vitamins and supplements that target vulnerable groups and for faster action when safety questions emerge.
Highlights
- Parents deserve clear labels and safe shelves
- Safety must outpace marketing in kids products
- Dispose of the product if in doubt and speak to a clinician
- Regulators need faster checks on supplements for children
Public health risk from unlisted melatonin in children's gummies
The recall points to safety concerns around labeling and undisclosed ingredients in a product aimed at children. Regulators warn of potential adverse effects and the possibility of harm if families rely on unverified claims about safety.
Regulators will watch how quickly warnings translate into safer market practices
Enjoyed this? Let your friends know!
Related News
MHRA safety alert for gummies
Recall of coriander and hummus in Northern Ireland
Wegmans Cheese Recalled for Listeria Risk
Turkey and ham meals recalled due to bacteria risk
Tesco recalls pasta products over salmonella risks
Tesco recalls pasta products over salmonella fears
Lidl recalls chicken product over health risk
Cheese recall issued for listeria and rodent concerns
